手機掃碼訪問本站
微信咨詢
猜你喜歡
- 6-O-乙酰氧-2,3,4-三(2-甲基丙酰氧)-β-D-呋喃果糖-6-乙酰基-1,3,4-三-O-(2-甲基-1-氧丙基)-α-D-吡喃葡糖苷
- trans-4-(2-Propynyl)-cyclohexanemethanol
- 3-溴-6-氯-1H-吡咯[3,2-C]吡啶
- 942919-26-87-氮雜吲哚-4-硼酸酯的制備方法
- 2-溴-3-碘-5-甲氧基-吡啶
- Fmoc-D-烯丙基甘氨酸
- N-METHYL-N-[(2-MORPHOLIN-4-YLPYRIDIN-4-YL)METHYL]AMINE
- METHYL 3-DEOXY-D-ARABINO-HEPTULOPYRANOSIDE-7-PHOSPHATE
- 5-硝基-2-羥基-3-氯吡啶
- 4-氯-1,6-二甲基-1H-吡唑并[3,4-D]嘧啶
- (S,S)-2,2′-異丙亞基雙(4-苯基-2-惡唑啉)
- 2,3,4,6-四-O-芐基-D-吡喃葡萄糖酰氟
- 86404-04-8 / 3-O-乙基抗壞血酸醚的制備和應用
- 碲化銻
- 2-甲基-4-惡唑甲醇
- (3R)-3-[[2-(1,3-Benzodioxol-5-ylcarbonyl)-1H-indol-3-yl]Methyl]-1-Methyl-2,5-piperazinedione
- 鹽酸沙夫肼
- 5-丙基-[1,3,4]噻二唑-2-胺
- 1,3,5-三甲基-3,7-二氮雜雙環[3.3.1]-9-壬醇
- N-Boc-4-氰基哌啶
- 142217-69-4 / 乙肝患者–恩替卡韋治療六年耐藥率僅為1.2%
- N-Propionyl Mesalazine-d5
- 2-氨基-2-(4-氟苯基)乙腈
- 4-叔丁基乙酰苯胺
- 2-萘基-2-基-苯并惡唑-5-基-胺
